Intravenous fat emulsion therapy for intentional sustained-release verapamil overdose.
Amy C Young, Larissa I Velez, Kurt C Kleinschmidt
Index: Resuscitation 80(5) , 591-3, (2009)
Full Text: HTML
Abstract
We report the first case of sustained-release verapamil toxicity treated with Intralipid fat emulsion (IFE). Toxicity was confirmed by elevated serial serum verapamil and metabolite, norverapamil, levels. Most previously reported cases of IFE therapy involve local anaesthetic toxicity and cardiac arrest. Our patient was in shock despite standard therapy. No adverse events were noted and the patient fully recovered.
Related Compounds
Related Articles:
2014-08-01
[J. Infect. Dis. 210(3) , 456-66, (2014)]
2013-09-01
[J. Pharm. Sci. 102(9) , 3161-73, (2013)]
Stereoselective CZE method for analysis of verapamil and norverapamil in human plasma.
2013-01-01
[Acta Pol. Pharm. 70(3) , 395-401, (2013)]
Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog.
1978-04-01
[Cardiovasc. Res. 12 , 247-254, (1978)]
The pharmacology of verapamil. V. Tissue distribution of verapamil and norverapamil in rat and dog.
1983-01-01
[Pharmacology 27 , 1-8, (1983)]